Navigation Links
Top-Line Preliminary Data From Phase II/III Study of Corthera's Relaxin in Acute Heart Failure to be Presented in Satellite Symposium at AHA Scientific Sessions 2008
Date:11/3/2008

nd commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in clinical trials for acute heart failure. Corthera has worldwide rights to develop and commercialize relaxin.

About the Satellite Symposium

Dr. Teerlink is the chair of the symposium and co-principal investigator of the Pre/RELAX-AHF study. Additional speakers will include Dr. Marco Metra, associate professor of cardiology, Department of Experimental and Applied Medicine, University of Brescia, Italy, and Dr. Gregg Fonarow, professor of medicine, UCLA School of Medicine. Dr. Metra is also co-principal investigator of the Pre/RELAX-AHF Study. Additional symposium information can be found at:
http://www.thrombo.net/tailoring-therapy/tailoring-therapy.pdf

Contact: Andreas Marathovouniotis or Ian Stone

Russo Partners

212.845.4235 or 619.814.3510

andreas.marathis@russopartnersllc.com

ian.stone@russopartnersllc.com


'/>"/>
SOURCE Corthera
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
2. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
3. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
4. YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION
5. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
6. CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Aidas Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer
9. Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial
10. Symmetry Medical Reports Preliminary Third Quarter Revenue
11. KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 22% for fiscal 2009; on track for positive ... 16 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) a ... today reported financial results for fourth quarter and ... 30, 2009, Microbix reported revenues of $6.08 million, ... 2008. For fourth-quarter 2009, the Company saw revenues ...
(Date:12/16/2009)... LLC introduces HSP-A Soy Peptone. HSP A has been found ... ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, LLC. ( ... HSP-A Soy Peptone. HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, ... to improve growth rates and yields. HSP-A has been found ...
(Date:12/15/2009)... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... ), a,leading fully integrated pharmaceutical company developing and ... ("PRC"), today,announced that the Company has 30 medicines ... the National Basic Medical Insurance, Industrial Injury Insurance,and ... The 30 medicines treat a variety of ...
(Date:12/15/2009)... PLYMOUTH, Minn., Dec. 15 The Mosaic Company (NYSE: ... quarter fiscal year 2010 earnings results and financial tables ... trading on the New York Stock Exchange. Results ... ,, The Company will host a conference call ... discuss the results. The call will begin at ...
Breaking Biology Technology:Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2
... July 25 Beckman,Coulter, Inc. (NYSE: BEC ... that simplify, automate and innovate complex biomedical,testing, announced ... 30, 2008,results. Total revenue of $798.3 million increased ... was up 11.2%. Net earnings were,$47.8 million, or ...
... Mind Foundation and conducted by TNS Teleseker, revealed that a majority ... methods that could "put them into a creative state and keep ... ... Jerusalem, Israel (PRWEB) July 26, 2008 -- A recent ...
... and SAN DIEGO, July 24 /PRNewswire-FirstCall/ - MIGENIX ... drugs for infectious,diseases, advises that the directors of ... (the "Meeting") to be held at 2:00 p.m. ... 2389 Health Sciences Mall, Vancouver,British Columbia. Further details ...
Other Biology Technology:Beckman Coulter Announces Second Quarter 2008 Results 2Beckman Coulter Announces Second Quarter 2008 Results 3Beckman Coulter Announces Second Quarter 2008 Results 4Beckman Coulter Announces Second Quarter 2008 Results 5Beckman Coulter Announces Second Quarter 2008 Results 6Beckman Coulter Announces Second Quarter 2008 Results 7Beckman Coulter Announces Second Quarter 2008 Results 8Beckman Coulter Announces Second Quarter 2008 Results 9Beckman Coulter Announces Second Quarter 2008 Results 10Beckman Coulter Announces Second Quarter 2008 Results 11Beckman Coulter Announces Second Quarter 2008 Results 12Beckman Coulter Announces Second Quarter 2008 Results 13Beckman Coulter Announces Second Quarter 2008 Results 14Beckman Coulter Announces Second Quarter 2008 Results 15Beckman Coulter Announces Second Quarter 2008 Results 16Beckman Coulter Announces Second Quarter 2008 Results 17Beckman Coulter Announces Second Quarter 2008 Results 18Beckman Coulter Announces Second Quarter 2008 Results 19Beckman Coulter Announces Second Quarter 2008 Results 20Beckman Coulter Announces Second Quarter 2008 Results 21Beckman Coulter Announces Second Quarter 2008 Results 22Beckman Coulter Announces Second Quarter 2008 Results 23Beckman Coulter Announces Second Quarter 2008 Results 24Beckman Coulter Announces Second Quarter 2008 Results 25Beckman Coulter Announces Second Quarter 2008 Results 26Beckman Coulter Announces Second Quarter 2008 Results 27Beckman Coulter Announces Second Quarter 2008 Results 28Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 3
(Date:12/16/2009)... source of financial and technical assistance to developing countries ... appear to be connected to space technology, but large ... intrinsically linked. , Global climate change is also an ... in the poorest countries and communities, which will suffer ... led to a growing demand for information about the ...
(Date:12/16/2009)... than 4 billion years before humans showed up, and ... That suggests they may have something to teach us. ... Prof. Eshel Ben-Jacob of the Raymond and Beverly Sackler ... of bacteria, presents compelling evidence to suggest there may ... opt for the swine flu H1N1 shot. , In ...
(Date:12/16/2009)... SUNNYVALE, Calif., Dec. 1 GestureTek ... CUBE, Release 3.0 - a turnkey, portable, ... for advertising, exhibits, entertainment and touring promotions. ... dozens of patents in camera-enabled gesture recognition ... systems. ,, Guaranteed for quality, the CUBE ...
Breaking Biology News(10 mins):ESA and World Bank move toward closer collaboration 2ESA and World Bank move toward closer collaboration 3ESA and World Bank move toward closer collaboration 4Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3The Leukemia 26 Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 52091 1The Leukemia 26 Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 52091 2The Leukemia 26 Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 52091 3Group Health Cooperative Scored Above Regional Average in 11 of 15 Quality Measures 52086 1Group Health Cooperative Scored Above Regional Average in 11 of 15 Quality Measures 52086 2Oncolytics Biotech 28R 29 Inc Completes Lyophilization Process for REOLYSIN 28R 29 13083 1Oncolytics Biotech 28R 29 Inc Completes Lyophilization Process for REOLYSIN 28R 29 13083 2
... marine biologists will gather in Auckland from 14-16 November to ... to the tropics. This major meeting of a global marine ... jointly hosted by the National Institute of Water & Atmospheric ... The Census of Marine Life is a ten-year initiative to ...
... confused feelings that occur when you meet someone whose ... his or her gender., A new study by neuroscientists ... processing of such sensory information about anothers gender to ... study concludes that it does, weighing in with findings ...
... There are many historical stories of shepherds and travellers ... of tales about attacks on flocks and people by ... of their former range, but for livestock owners around ... a daily reality. Although loss of human life is ...
Other Biology News:Hearing changes how we perceive gender 2Hearing changes how we perceive gender 3Hearing changes how we perceive gender 4Living with lions 2
... Vesicular Monoamine Transporter 2 (VMAT2). An antibody ... a major band at ~55 kDa in ... and not in wild type cells (2). ... molecular weight, were also detected and remain ...
... INK4a-ARF locus encodes two unrelated proteins both ... arrests the cell cycle in a p53-dependent ... the rapid degradation of mdm2 proteinrequired for ... accumulation. This interaction is mediated by ...
... immunoblotting the antibody reacts against the reduced ... MMP-2 or MMP-2 bound to TIMP-2. affinity ... Solution in 0.01 M phosphate buffered ... 15 mM sodium azide. synthetic peptide corresponding ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Mfr Desig: ...
Biology Products: